Access cutting-edge breast cancer treatment through this clinical trial at a research site in Pontiac. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Pontiac at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This Phase III, randomized, two-arm, open-label, multicenter study will evaluate the efficacy and safety of giredestrant plus Phesgo compared with Phesgo after induction therapy with Phesgo plus taxane in participants with human epidermal growth factor receptor 2 (HER2)-positive, estrogen receptor (ER)-positive advanced breast cancer (metastatic or locally advanced disease not amenable to curative treatment) who have not previously received a systemic non-hormonal anti-cancer therapy in the adva
Sponsor: Hoffmann-La Roche
Check if you qualify for this breast cancer clinical trial in Pontiac, MI
If you're searching for breast cancer treatment options in Pontiac, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Pontiac research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.